257 related articles for article (PubMed ID: 4769022)
1. [Clinical evaluation of Rhytmodan in heart rhythm disorders].
Dzieglielewski T; Wachowiak A
Pol Tyg Lek; 1973 Dec; 28(52):2065-7. PubMed ID: 4769022
[No Abstract] [Full Text] [Related]
2. Clinical studies of Norpace (Part V).
Cook WR
Angiology; 1975 Jan; 26(1 Pt 2):140-1. PubMed ID: 1115401
[No Abstract] [Full Text] [Related]
3. Clinical studies of Norpace (Part I).
Smith WS
Angiology; 1975 Jan; 26(1 Pt 2):124-31. PubMed ID: 1090212
[No Abstract] [Full Text] [Related]
4. Clinical studies of Norpace. Summarizing remarks.
Fowler NO
Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
[No Abstract] [Full Text] [Related]
5. Clinical studies of Norpace (Part IV).
Jutzy RV
Angiology; 1975 Jan; 26(1 Pt 2):138-9. PubMed ID: 803798
[No Abstract] [Full Text] [Related]
6. Clinical studies of Norpace (Part II).
Vismara L
Angiology; 1975 Jan; 26(1 Pt 2):132-6. PubMed ID: 1090213
[No Abstract] [Full Text] [Related]
7. Clinical studies of Norpace (Part XI).
Nisbet T
Angiology; 1975 Jan; 26(1 Pt 2):149-53. PubMed ID: 46729
[No Abstract] [Full Text] [Related]
8. [Disopyramide in heart arrhythmias].
Pellegrino L; Di Michele A; Prencipe D
Boll Soc Ital Cardiol; 1972; 17(8):617-25. PubMed ID: 4655948
[No Abstract] [Full Text] [Related]
9. [Remote results of the treatment of rhythm disturbances with disopyramide].
Desruelles J; Gerard A
Arch Mal Coeur Vaiss; 1970 Feb; 63(2):182-9. PubMed ID: 4191762
[No Abstract] [Full Text] [Related]
10. [Therapeutic value of Rhytmodan in the management of ectopic arrhythmias].
Woyda J
Pol Tyg Lek; 1972 Dec; 27(50):1985-8. PubMed ID: 4649232
[No Abstract] [Full Text] [Related]
11. The hemodynamic effects of Norpace (Part I).
Befeler B
Angiology; 1975 Jan; 26(1 Pt 2):99-101. PubMed ID: 1115404
[No Abstract] [Full Text] [Related]
12. Clinical studies of Norpace (Part VII).
Berman R
Angiology; 1975 Jan; 26(1 Pt 2):143. PubMed ID: 1090214
[No Abstract] [Full Text] [Related]
13. The electrophysiology of Norpace (Part III).
Caracta A
Angiology; 1975 Jan; 26(1 Pt 2):120-3. PubMed ID: 1115399
[No Abstract] [Full Text] [Related]
14. The hemodynamic effects of Norpace. (Part II).
Willis PW
Angiology; 1975 Jan; 26(1 Pt 2):102-10. PubMed ID: 1115396
[No Abstract] [Full Text] [Related]
15. [Effect of intravenous disopyramide in supraventricular paroxysmal tachycardia refractory to vagal maneuvers].
Romero-Ayala LC; Soní J
Arch Inst Cardiol Mex; 1983; 53(2):147-51. PubMed ID: 6882095
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
[No Abstract] [Full Text] [Related]
17. [Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
Lisin N; Andriange M; Vandenbosch R; Carlier J
Rev Med Liege; 1974 May; 29(9):256-64. PubMed ID: 4134825
[No Abstract] [Full Text] [Related]
18. Clinical studies of Norpace (Part IX).
Oshrain C
Angiology; 1975 Jan; 26(1 Pt 2):146-7. PubMed ID: 123135
[No Abstract] [Full Text] [Related]
19. Clinical studies of Norpace (Part III).
Kalmansohn RG
Angiology; 1975 Jan; 26(1 Pt 2):137. PubMed ID: 1115400
[No Abstract] [Full Text] [Related]
20. Disopyramide.
Koch-Weser J
N Engl J Med; 1979 Apr; 300(17):957-62. PubMed ID: 431563
[No Abstract] [Full Text] [Related]
[Next] [New Search]
